Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Female Pelvic Med Reconstr Surg. 2021 Jan 1;27(1):e39–e44. doi: 10.1097/SPV.0000000000000790

Figure 3. Vaginal estrogen therapy decrease IL-6 production in postmenopausal women with a history of recurrent UTI.

Figure 3.

(A) At baseline, patients with rUTI not on VET demonstrate higher IL-6 in the urine than patients already on VET with (Group 1) and without (Group 2) VET. (B) Urine IL-6 levels decreased significantly after 3 months of VET in patients with rUTIs. rUTI, recurrent urinary tract infections; VET, vaginal estrogen therapy. Bars represent mean ± SEM.*p<0.05.